Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Interventional Study Dealing With the Use of Trabectedin (Yondelis®)-Pegylated Liposomal Doxorubicin (Caelyx®) in Patient With Platinum-sensitive Relapse

NCT02163720 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.

NCT NCT02163720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02163720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Interventional Study Dealing With the Use of Trabectedin (Yondelis®)-Pegylated Liposomal Doxorubicin (Caelyx®) in Patient With Platinum-sensitive Relapse
Lead sponsor
ARCAGY/ GINECO GROUP
Phase
Observational
Overall status
Completed
Start date
July 10, 2014
Completion date
September 18, 2018
Enrollment
101 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer